CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

[1]  A. Pettitt,et al.  CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. , 2001, Blood.

[2]  R. Rosenquist,et al.  CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. , 2001, Blood.

[3]  S. Deaglio,et al.  Human CD38: a (r)evolutionary story of enzymes and receptors. , 2001, Leukemia research.

[4]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[5]  B. Cheson,et al.  Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[6]  T J Hamblin,et al.  Immunoglobulin V genes and CD38 expression in CLL. , 2000, Blood.

[7]  U. Dianzani,et al.  CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. , 2000, Chemical immunology.

[8]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[9]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[10]  Binet Jl.  Prognostic factors in chronic lymphocytic leukaemia. , 1999 .

[11]  K. Rai.  Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment. , 1999, Haematologica.

[12]  Sofia Quintero Romero,et al.  Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases. , 1999, Haematologica.

[13]  J. Binet.  Prognostic factors in chronic lymphocytic leukaemia. , 1999, Haematologica.

[14]  A. Órfão,et al.  The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). , 1998, Blood.

[15]  L. Kanz,et al.  Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer. , 1998, Seminars in oncology.

[16]  B. Cheson,et al.  Chronic lymphocytic leukemia: staging and prognostic factors. , 1998, Seminars in oncology.

[17]  M. Uppenkamp,et al.  Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry , 1996, Clinical and diagnostic laboratory immunology.

[18]  E. Paietta.  Proposals for the immunological classification of acute leukemias. , 1995, Leukemia.

[19]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[20]  K.,et al.  Ligation of CD38 suppresses human B lymphopoiesis , 1995, The Journal of experimental medicine.

[21]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[22]  D C Case,et al.  Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.